This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2017-04-06 Patient Care FHIR Call"
Jump to navigation
Jump to search
(→Zulip) |
|||
| (20 intermediate revisions by the same user not shown) | |||
| Line 53: | Line 53: | ||
|- | |- | ||
<!-- ********add attendee information here *********--> | <!-- ********add attendee information here *********--> | ||
| − | | || Elaine Ayres | + | |X || Elaine Ayres |
|colspan="2"| NIH/Department of Clinical Research Informatics | |colspan="2"| NIH/Department of Clinical Research Informatics | ||
|- | |- | ||
| Line 59: | Line 59: | ||
|colspan="2"| | |colspan="2"| | ||
|- | |- | ||
| − | | || Stephen Chu | + | | X|| Stephen Chu |
|colspan="2"| The Australian Digital Health Agency (ADHA) | |colspan="2"| The Australian Digital Health Agency (ADHA) | ||
|- | |- | ||
| Line 68: | Line 68: | ||
|colspan="2"| Haas Consulting | |colspan="2"| Haas Consulting | ||
|- | |- | ||
| − | | || Rob Hausam | + | | X|| Rob Hausam |
|colspan="2"| Hausam Consulting LLC | |colspan="2"| Hausam Consulting LLC | ||
|- | |- | ||
| Line 74: | Line 74: | ||
|colspan="2"| Intermountain Healthcare | |colspan="2"| Intermountain Healthcare | ||
|- | |- | ||
| − | | || Emma Jones | + | | X|| Emma Jones |
|colspan="2"| Allscripts | |colspan="2"| Allscripts | ||
|- | |- | ||
| − | | || Russ Leftwich | + | | X|| Russ Leftwich |
|colspan="2"| InterSystems | |colspan="2"| InterSystems | ||
|- | |- | ||
| − | | || Tony Little | + | | X|| Tony Little |
|colspan="2"| Optum 360 | |colspan="2"| Optum 360 | ||
|- | |- | ||
| Line 95: | Line 95: | ||
|colspan="2"| Cerner | |colspan="2"| Cerner | ||
|- | |- | ||
| − | | | + | | X || Michelle M Miller |
|colspan="2"| Cerner | |colspan="2"| Cerner | ||
|- | |- | ||
| Line 110: | Line 110: | ||
|colspan="2"| Intermountain Healthcare | |colspan="2"| Intermountain Healthcare | ||
|- | |- | ||
| − | | || Joe Quinn | + | | X|| Joe Quinn |
|colspan="2"| Optum | |colspan="2"| Optum | ||
|- | |- | ||
| Line 121: | Line 121: | ||
| || Serafina Versaggi | | || Serafina Versaggi | ||
|colspan="2"| Dept of Veterans Affairs | |colspan="2"| Dept of Veterans Affairs | ||
| + | |- | ||
| + | | || Bob Milius | ||
| + | |colspan="2"| NMDP | ||
| + | |- | ||
| + | | || Kirt Schaper | ||
| + | |colspan="2"| CIBMTR | ||
| + | |- | ||
| + | | X|| Mike Padula | ||
| + | |colspan="2"| CHOP | ||
|- | |- | ||
|colspan="4" style="background:#f0f0f0;"| | |colspan="4" style="background:#f0f0f0;"| | ||
| Line 145: | Line 154: | ||
#Agenda review | #Agenda review | ||
#Approve previous meeting minutes [[2017-03-23_Patient_Care_FHIR_Call]] | #Approve previous meeting minutes [[2017-03-23_Patient_Care_FHIR_Call]] | ||
| − | #*'''Motion:''' | + | #*'''Motion:''' Russ/Stephen |
# Zulip topics | # Zulip topics | ||
# Prior Action Item Follow-up | # Prior Action Item Follow-up | ||
| Line 169: | Line 178: | ||
=== Zulip === | === Zulip === | ||
| − | * [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation] | + | * [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation] -- Deferred until Bob or Kirt can attend |
| − | ** NMDP and CIBTMR would like to participate in helping develop a new resource for transplant material | + | ** NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material |
** It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc | ** It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc | ||
| − | + | ** Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”) | |
| + | ** Previously, Patient Care had voted to create a new resource, per [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458] | ||
* [https://chat.fhir.org/#narrow/stream/implementers/topic/Preferred.20pharmacist CareTeam for Preferred Pharmacist?] | * [https://chat.fhir.org/#narrow/stream/implementers/topic/Preferred.20pharmacist CareTeam for Preferred Pharmacist?] | ||
| + | ** CareTeam doesn't feel like the right way to convey preferred pharmacy (more of an organization or location, than a person) | ||
| + | ** More like preferred supplier; may depend on PBM | ||
| + | ** Pharmacists can be members of a care team, such as oncology patient who might have a clinical pharmacist as part of the care team | ||
| + | ** Talk to PA to see if GP should be "patient preferred providers" to loosen scope to all preferred providers | ||
| + | ** Talk to Pharm about ePrescribing workflow - where/how the preferred pharmacy is communicated in context of a specific MedicationRequest | ||
=== Prior Action Items === | === Prior Action Items === | ||
| − | [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=13004 GF#13004] extension-condition-criticality needs a binding to a value set | + | [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=13004 GF#13004] extension-condition-criticality needs a binding to a value set -- resolved! |
[https://chat.fhir.org/#narrow/stream/implementers/topic/Condition.20criticality.20extension No implementer feedback] | [https://chat.fhir.org/#narrow/stream/implementers/topic/Condition.20criticality.20extension No implementer feedback] | ||
=== gForge Change Requests === | === gForge Change Requests === | ||
| + | * [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=13047 GF#13047] Add DosageInstructions to Procedure (Jamie Hignite) - related to [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12966 GF#12966] ProcedureRequest - add DosageInstructions or Quantity -- remains deferred | ||
| + | * [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=13046 GF#13046] Add relevantHistory 0..* Provance to Procedure (Jamie Hignite) -- waiting for input from Jamie | ||
| + | * [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=13087 GF#13087] Create example for no known allergies (Rick Geimer) -- resolved! | ||
=== Adjourn === | === Adjourn === | ||
| − | Adjourned at | + | Adjourned at 6:32pm Eastern |
==Meeting Outcomes== | ==Meeting Outcomes== | ||
Latest revision as of 22:37, 6 April 2017
Contents
Meeting Information
| Patient Care FHIR Resources Conference Call Location: Conference Call |
Date: 2017-04-06 Time: 5-6:30pm ET | ||
| Facilitator | Michelle M Miller | Note taker(s) | Michelle M Miller |
| Attendee | Name | Affiliation
| |
| X | Elaine Ayres | NIH/Department of Clinical Research Informatics | |
| Pushpalatha Bhat | |||
| X | Stephen Chu | The Australian Digital Health Agency (ADHA) | |
| Evelyn Gallego | EMI Advisors LLC | ||
| Eric Haas | Haas Consulting | ||
| X | Rob Hausam | Hausam Consulting LLC | |
| Laura Heermann-Langford | Intermountain Healthcare | ||
| X | Emma Jones | Allscripts | |
| X | Russ Leftwich | InterSystems | |
| X | Tony Little | Optum 360 | |
| Jay Lyle | Ockham Information Services LLC, VA | ||
| Russell McDonell | Telstra Health | ||
| Lloyd McKenzie | Gevity (HL7 Canada) | ||
| Larry McKnight | Cerner | ||
| X | Michelle M Miller | Cerner | |
| Lisa Nelson | Life Over Time Solutions | ||
| Viet Nguyen | Lockheed Martin, Systems Made Simple | ||
| M'Lynda Owens | Cognosante | ||
| Craig Parker | Intermountain Healthcare | ||
| X | Joe Quinn | Optum | |
| Simon Sum | Academy of Nutrition and Dietetics | ||
| Iona Thraen | Dept of Veterans Affairs | ||
| Serafina Versaggi | Dept of Veterans Affairs | ||
| Bob Milius | NMDP | ||
| Kirt Schaper | CIBMTR | ||
| X | Mike Padula | CHOP | |
| Quorum Requirements Met: yes | |||
Agenda
Agenda Topics
- Agenda review
- Approve previous meeting minutes 2017-03-23_Patient_Care_FHIR_Call
- Motion: Russ/Stephen
- Zulip topics
- Prior Action Item Follow-up
- gForge change request
Supporting Information
- Tracker Issues - https://docs.google.com/a/lmckenzie.com/uc?id=0B285oCHDUr09Mzh3b09rMFhEV1E
- Resolve QA Warnings to have resource FMM > 0
- Resolve QA Information messages to achieve FMM = 3
- Maintain QA checklist
Minutes
Zulip
- Blood, Tissue, Organ Donation -- Deferred until Bob or Kirt can attend
- NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
- It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc
- Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
- Previously, Patient Care had voted to create a new resource, per GF#8458
- CareTeam for Preferred Pharmacist?
- CareTeam doesn't feel like the right way to convey preferred pharmacy (more of an organization or location, than a person)
- More like preferred supplier; may depend on PBM
- Pharmacists can be members of a care team, such as oncology patient who might have a clinical pharmacist as part of the care team
- Talk to PA to see if GP should be "patient preferred providers" to loosen scope to all preferred providers
- Talk to Pharm about ePrescribing workflow - where/how the preferred pharmacy is communicated in context of a specific MedicationRequest
Prior Action Items
GF#13004 extension-condition-criticality needs a binding to a value set -- resolved!
gForge Change Requests
- GF#13047 Add DosageInstructions to Procedure (Jamie Hignite) - related to GF#12966 ProcedureRequest - add DosageInstructions or Quantity -- remains deferred
- GF#13046 Add relevantHistory 0..* Provance to Procedure (Jamie Hignite) -- waiting for input from Jamie
- GF#13087 Create example for no known allergies (Rick Geimer) -- resolved!
Adjourn
Adjourned at 6:32pm Eastern
Meeting Outcomes
| Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2012 Health Level Seven® International. All rights reserved.
